Upload
wocova
View
219
Download
1
Embed Size (px)
Citation preview
Safety of Intraosseous Vascular Access in the 21st Century
John J. Rogers, MD, FACS,FACEP
ED Medical Director Coliseum Health System, Macon, Georgia, USA
Board of Directors American College of Emergency Physicians
Disclosures
Travel Related Expenses to AKend this Conference
Disclaimer
Opinions and Statements are My Own
Not Policies or Opinions of ACEP
The Dream
The Reality
The Problem
IV Cannot Be Started in over 5 Million
IV Extremely Difficult in over 7 Million
Anxiety and Panic
Thousands Die Every Year
Current SoluTons to IV Failure
EMS ET, SQ, IM, Rectal, Oral, Nasal,
InhalaTon, Sublingual, Transdermal
Drive FASTER
Current SoluTons to IV Failure
Emergency Department
Central Venous Lines
Time to Insert Resources – Staff and Equipment (US)
Training 400,000 complications/year (FDA)
$2,300 or more per complication (CDC) More than 10 % mortality
Central Venous Line Challenges – 5 million central lines placed annually – 500,000 strictly for rapid vascular access – Complications in up to 26% – Infections cost $50,000+ per episode – Safe placement up to 20 minutes
Initiatives to decrease complications – Medicare will not pay for complications – Aim for Zero Campaign – National Patient Safety Goals
NPSG 07.04.01 Implement evidence based precauTons to prevent central line associate bloodstream
infecTons.
Avoid Central Lines
Alternative Methods of Vascular Access in the ED
ACEP Clinical Policy Board of Directors June 2011
Current SoluTons to IV Failure
Alternative – Intraosseous Access (IO)
Standard of care in pediatrics and adults
Recommended if no IV can be established rapidly Safety and efficacy proven in thousands of cases
Has Saved Hundreds of Lives
Thousands of small veins lead from the medullary space to the central circulation
The Ideal IO
Easy
Safe
EffecTve
Fast
Intraosseous (IO) Vascular Access
• Inside the bone is a huge non-collapsible vein
• All drugs reach the circulation the same as IV
• Volume of up to 9 Liters per hour (EZ-IO)
• Pain of insertion equivalent to peripheral (EZ-IO)
• Lab studies, Blood Type
• Lytic therapy, SVT with Adenosine, RSI
• Can be learned easily (EZ-IO)
• Can be inserted quickly (EZ-IO)
• Technology was possible in kids because their bones are soft
ComplicaTons – Commonly Reported
Severity Frequent Occasional Rare
Serious DVT(30%*) InfecTon (5-‐9%) DVT (8 – 26%) PE (15 %*)
Arterial puncture (3.5%)
Death InfecTon (1%) Air Embolism (0.5%) Bleed/Pneumo (1-‐3%)
Less Serious Hematoma (4.5%)
Minor MalposiTon (9%)
Severity Frequent Occasional Rare
Serious OsteomyeliTs (0.6%)
Less Serious ExtravasaTon (0.8%) SQ abscess (0.1%)
Minor Leakage (0.4%) Removal problems (0.2%)
Central Venous Catheters
Intraosseous Access Catheters
Landmark Study Rosef et al 1985
Meta-‐analysis of 30 studies involving 4,270 paTents Only 37 complicaTons reported
OsteomyeliTs most prevalent (n=27) at 0.6% Device leh in place many days – weeks
Needed: Update of Rosef’s Numbers
27 years later, Rosef’s 0.6% sTll quoted
But…IO has drasTcally changed since 1985 BeKer devices Greater uTlity
BeKer Guidelines for use dwell-‐Tme ≤ 24 hours (USA) up to 72 hours in Europe
frequent site checks contraindicaTons
Methods
Literature search – Pub Med – Google – Vidacare’s IO access bibliography
• Available at vidacare.com
Checked FDA’s Manufacturer and User Facility Device Experience (MAUDE) database for Medical Device Reports (MDRs) from manufacturers
– Available at accessdata.fda.gov
Intraosseous Vascular Access Serious ComplicaTons Found in the Literature: Osteomyeli*s
Since Rosef (1985), only single cases cited in literature
• PlaK et al (1993): 2-‐1/2 month old with IO needle leh in place 3 days, resulted in fungal osteomyeliTs; treated/recovered
• Rosovsky et al (1994): 14 month old with bilateral femoral osteomyeliTs
• Barron (1994): 20 month old with Tbial osteomyeliTs; treated/recovered
• Stoll et al (2001): 3 month old with Tbial osteomyeleTs aher adrenalin infusion; required orthopedic stabilizaTon surgery for recovery
• Dogan et al (2004): 5 month old with Tbial osteomyeliTs; treated/recovered
• Henson (2010): 62 year old with co-‐morbidiTes including diabetes, MRSA colonizaTon; had Tbial IO; presented 6 months later with osteomyeliTs
Intraosseous Vascular Access Serious ComplicaTons Found in the Literature: Other
Cases since Rosef (1985)
Compartment syndrome: 18 Fracture: 3
Skin necrosis: 2 Suspected air embolism: 2
Compartment Syndrome
Atanda 2008, Am J Ortho:
“With proper aKenTon to detail and serial monitoring of the involved limb, compartment syndrome and other potenTal complicaTons of IO line placement can be avoided.”
Compartment Syndrome
Taylor and Clark, 2011 BMJ
Compartment syndrome leading to amputaTon
“by day 7 the right limb was perfused but the leh had become demarcated to the mid calf level.”
Compartment Syndrome
Waltzman, Harvard Medical School: “To aKribute the rare complicaTon of compartment syndrome to these devices and not to either the technique of inserTon or lack of careful monitoring is unfortunate. These devices have been shown to decrease the Tme needed to obtain vascular access and speed the delivery of fluids and medicaTons, thereby saving the lives of many children.”
Compartment Syndrome
Waltzman, Harvard Medical School:
Hand driven placement of IO needles are also misplaced either due to incomplete placement in the marrow space or penetraTon through the posterior cortex….it is not the needle type that results in extravasaTon, but the difficulty with inserTon and penetraTon of both corTces during stressful emergency situa*ons.”
Compartment Syndrome
Moen and Sarwark 2008, Orthopedics
1 case following difficult resuscitaTon recognized immediately
Lesson Use correct needle size, don’t force the drill, watch for extravasaTon early especially when giving large fluid volumes, parTcularly in children.
EZ-‐IO Intraosseous Vascular Access Serious ComplicaTons
Found on the FDA Website*
Compartment Syndrome: 4 OsteomyeliTs: 1
In over 1 million inserTons
*Source: www.accessdata.fda.gov/scripts/cdrh/cfdocs/dfMAUDE/search.cfm
A Myth That Lives On Example from 2005
Summary • Simple extravasaTon most prevalent complicaTon: <5% of IO placements
• OsteomyeliTs not a great concern – 6 cases reported in literature – 1 case reported to FDA by MDR (EZ-‐IO)
• 1 case out of >1 million placements = <0.0001%
• Compartment syndrome is greater concern – 18 cases reported in literature since 1985 – Most cases secondary to undetected extravasaTon – Indicates need for closer monitoring of IO site
• Other serious complicaTons (e.g. air embolism, fracture) excep*onally rare
Difficult Vascular Access OpTons Intraosseous Central Peripheral
Time 6 – 30 seconds 10 – 26 minutes 20 -‐39 minutes
ComplicaDons < 1% 15 % 32-‐70 %
Success 90 – 98 % 60 – 89 % 33 – 77 %
First AKempt 90 – 97 % 22 – 86 % 49 – 71 %
Staff Nurse Dr /APP + Assistant Nurse
Equipment IO Needle/Device Kit, Mask/Gown/Drape/US
Catheter
Flow Rate Moderate to High High Depends on gauge
Cost $ 100 $290 $ 32 /aKempt $ 96 / 3 aKempts
Conclusions With new devices and techniques
IO is SAFE
IO is EFFECTIVE
IO is EASY
IO is FAST
Why not IO?